Christopher Young

This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Vertex Pharmaceuticals, Inc., Intelligent Meetings Corp.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher Young. Retrieved from https://idiyas.com/inventor/christopher-young-6oqyxssk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 3.5

ph-index = 15

Forward Citations = 940(Granted Patents)

Location History:

Mashpee, MA (US) (2005)
Sudbury, MA (US) (2015)
Waltham, MA (US) (2009 - 2023)

Company Filing History:

18 out of 1,168

Vertex Pharmaceuticals, Inc.

patents

1 out of 1

Intelligent Meetings Corp.

patent

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Pharmaceutical Composition

Solid Forms

Dosage Units

Carboxamide

Hydroxyphenyl

Dioxol

Cyclopropanecarboxamide

3-Methylpyridin

Benzoic Acid

Administration

N-Difluorobenzo

Oxoquinoline

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458635 - Pharmaceutical composition and administrations thereof (2025-11-04),

2. 11564916 - Pharmaceutical composition and administrations thereof (2023-01-31),

3. 11291662 - Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2022-04-05),

4. 11052075 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof (2021-07-06),

5. 10646481 - Pharmaceutical composition and administrations thereof (2020-05-12),

6. 10537565 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2020-01-21),

7. 10076513 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid and administration thereof (2018-09-18),

8. 9931334 - Solid forms of N[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2018-04-03),

9. 9670163 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2017-06-06),

10. 9241934 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof (2016-01-26),

11. 9192606 - Dosage units of 3-(6-(1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (2015-11-24),

12. 9139530 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2015-09-22),

13. 8754224 - Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (2014-06-17),

14. 8716338 - Dosage units of 3-(6-(1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid (2014-05-06),

15. 8552034 - Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid and administration thereof (2013-10-08),

Certainly! Here is the article about inventor Christopher Young:

Title: Innovator Spotlight: Christopher Young - Pioneering Pharmaceutical Solutions in Waltham, MA

Introduction: Christopher Young, a distinguished inventor based in Waltham, MA, is renowned for his groundbreaking work in the field of pharmaceutical compositions. With an impressive track record of 17 patents to his name, Young continues to revolutionize the industry with his innovative solutions.

Latest Patents: Among his recent achievements are patents for "Pharmaceutical composition and administrations thereof" and "Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide". These inventions highlight his expertise in developing novel pharmaceutical formulations and methods of administration, pushing the boundaries of medical science.

Career Highlights: Christopher Young is a key member of the research and development team at Vertex Pharmaceuticals, Inc. His contributions have not only propelled the company's success but have also benefited the broader pharmaceutical community. Young's keen insights and dedication have made him a leading figure in the industry.

Collaborations: In his collaborative efforts, Christopher Young has worked closely with esteemed colleagues such as Patricia Nell Hurter and William Rowe. Together, they have synergized their expertise to drive innovation, resulting in impactful solutions that have reshaped the landscape of pharmaceuticals.

Conclusion: Christopher Young's unwavering commitment to advancing pharmaceutical research and development underscores his significance as a visionary inventor. With a strong foundation of patents and a spirit of collaboration, Young continues to inspire change and shape the future of medicine.

Thank you for providing the information about this outstanding innovator! If you have any more requests or need further assistance, feel free to let me know.

Profile summary based on public USPTO records.